Baidu
map

Cancer:基因测序发现男性乳腺癌的易感基因——PALB2

2016-09-30 MedSci MedSci原创

男性乳腺癌是一种罕见的疾病,只占所有乳腺癌当中的0.6%,而且在所有男性癌症当中占不到1%。遗传因素是男性乳腺癌发生的重要原因。不管是先天因素还是后天因素所导致,雄性激素缺乏、雌性激素分泌过多的男性,都更容易罹患乳腺癌。 与女性乳腺癌比较,男性乳腺癌发现时往往较为晚期,所以肿瘤会比较大,也常伴随有淋巴结的转移。

男性乳腺癌是一种罕见的疾病,只占所有乳腺癌当中的0.6%,而且在所有男性癌症当中占不到1%。遗传因素是男性乳腺癌发生的重要原因。不管是先天因素还是后天因素所导致,雄性激素缺乏、雌性激素分泌过多的男性,都更容易罹患乳腺癌。 与女性乳腺癌比较,男性乳腺癌发现时往往较为晚期,所以肿瘤会比较大,也常伴随有淋巴结的转移。


但是,由BRCA1和BRCA2基因突变导致的MBC约占其总数的10%。因此,一些MBC病例是否是由遗传因素导致的,尚未确定。为了进一步解释MBC的遗传易感性,全基因组测序(WES)和有针对性的基因测序方法被用于高风险、BRCA1 / 2突变阴性的MBC患者。

研究人员对有MBC First-degree家族史的家族中的1个男性和2个女性BRCA1/2突变阴性乳腺癌(BC)病例的生殖细胞DNA进行WES分析。BRCA1/ 2突变阴性MBC病例的意大利多中心研究,通过针对性的基因测序验证WES结果,发现了48个高风险基因。最终病例对照数据包括433个BRCA1/ 2突变阴性MBC与女性乳腺癌(FBC)病例,以及849例男性和女性(对照组)被纳入研究。

结果显示,家族中的WES发现PALB2 c.419delA突变的先证者,突变的携带者是她的父亲和她的叔叔(父系)(所有BC都受影响),NAT1 c.97C > T突变的携带者是先证者的阿姨(母系)。针对性的基因测序发现四十八分之一的BRCA1/2突变阴性MBC病例有c.1984A >T。病例对照未发现NAT1 c.97C >T。

这些结果强有力地证明了PALB2与男性及女性乳腺癌风险有关,提示应更多得对家族中有较多MBC及FBC病例但BRCA1 / 2突变阴性人群以临床研究。

原始出处:

Silvestri V1, Zelli V,et al.Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility gene.Cancer. 2016 Sep 20. doi: 10.1002/cncr.30337. [Epub ahead of print]

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (14)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=158795, encodeId=5982158e95cd, content=基因测序发现男性乳腺癌的易感基因——PALB2, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160903/IMG57CA05C7ADAC62159.jpg, createdBy=ea6c1943408, createdName=镱鉎鉌釚, createdTime=Tue Nov 29 07:04:08 CST 2016, time=2016-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=143102, encodeId=6bde143102c6, content=文章很好,继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Mon Oct 10 10:59:35 CST 2016, time=2016-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139490, encodeId=9d2f13949028, content=PALB2与男性及女性乳腺癌风险有关,提示应更多得对家族中有较多MBC及FBC病例但BRCA1 / 2突变阴性人群以临床研究。, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160923/IMG57E54D670B3C08868.jpg, createdBy=e90b1956497, createdName=Carlos007, createdTime=Mon Oct 03 11:49:04 CST 2016, time=2016-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139131, encodeId=69251391318d, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sun Oct 02 17:54:22 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139130, encodeId=1835139130b8, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sun Oct 02 17:54:17 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139047, encodeId=60fc13904e36, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:05:23 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139046, encodeId=7cd11390466c, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:05:18 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139045, encodeId=39e51390456e, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:05:09 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139044, encodeId=e476139044dc, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:05:01 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139043, encodeId=2402139043d7, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:04:53 CST 2016, time=2016-10-02, status=1, ipAttribution=)]
    2016-11-29 镱鉎鉌釚

    基因测序发现男性乳腺癌的易感基因——PALB2

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=158795, encodeId=5982158e95cd, content=基因测序发现男性乳腺癌的易感基因——PALB2, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160903/IMG57CA05C7ADAC62159.jpg, createdBy=ea6c1943408, createdName=镱鉎鉌釚, createdTime=Tue Nov 29 07:04:08 CST 2016, time=2016-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=143102, encodeId=6bde143102c6, content=文章很好,继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Mon Oct 10 10:59:35 CST 2016, time=2016-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139490, encodeId=9d2f13949028, content=PALB2与男性及女性乳腺癌风险有关,提示应更多得对家族中有较多MBC及FBC病例但BRCA1 / 2突变阴性人群以临床研究。, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160923/IMG57E54D670B3C08868.jpg, createdBy=e90b1956497, createdName=Carlos007, createdTime=Mon Oct 03 11:49:04 CST 2016, time=2016-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139131, encodeId=69251391318d, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sun Oct 02 17:54:22 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139130, encodeId=1835139130b8, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sun Oct 02 17:54:17 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139047, encodeId=60fc13904e36, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:05:23 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139046, encodeId=7cd11390466c, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:05:18 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139045, encodeId=39e51390456e, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:05:09 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139044, encodeId=e476139044dc, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:05:01 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139043, encodeId=2402139043d7, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:04:53 CST 2016, time=2016-10-02, status=1, ipAttribution=)]
    2016-10-10 1e10c84am36(暂无匿称)

    文章很好,继续关注

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=158795, encodeId=5982158e95cd, content=基因测序发现男性乳腺癌的易感基因——PALB2, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160903/IMG57CA05C7ADAC62159.jpg, createdBy=ea6c1943408, createdName=镱鉎鉌釚, createdTime=Tue Nov 29 07:04:08 CST 2016, time=2016-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=143102, encodeId=6bde143102c6, content=文章很好,继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Mon Oct 10 10:59:35 CST 2016, time=2016-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139490, encodeId=9d2f13949028, content=PALB2与男性及女性乳腺癌风险有关,提示应更多得对家族中有较多MBC及FBC病例但BRCA1 / 2突变阴性人群以临床研究。, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160923/IMG57E54D670B3C08868.jpg, createdBy=e90b1956497, createdName=Carlos007, createdTime=Mon Oct 03 11:49:04 CST 2016, time=2016-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139131, encodeId=69251391318d, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sun Oct 02 17:54:22 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139130, encodeId=1835139130b8, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sun Oct 02 17:54:17 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139047, encodeId=60fc13904e36, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:05:23 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139046, encodeId=7cd11390466c, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:05:18 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139045, encodeId=39e51390456e, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:05:09 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139044, encodeId=e476139044dc, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:05:01 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139043, encodeId=2402139043d7, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:04:53 CST 2016, time=2016-10-02, status=1, ipAttribution=)]
    2016-10-03 Carlos007

    PALB2与男性及女性乳腺癌风险有关,提示应更多得对家族中有较多MBC及FBC病例但BRCA1 / 2突变阴性人群以临床研究。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=158795, encodeId=5982158e95cd, content=基因测序发现男性乳腺癌的易感基因——PALB2, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160903/IMG57CA05C7ADAC62159.jpg, createdBy=ea6c1943408, createdName=镱鉎鉌釚, createdTime=Tue Nov 29 07:04:08 CST 2016, time=2016-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=143102, encodeId=6bde143102c6, content=文章很好,继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Mon Oct 10 10:59:35 CST 2016, time=2016-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139490, encodeId=9d2f13949028, content=PALB2与男性及女性乳腺癌风险有关,提示应更多得对家族中有较多MBC及FBC病例但BRCA1 / 2突变阴性人群以临床研究。, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160923/IMG57E54D670B3C08868.jpg, createdBy=e90b1956497, createdName=Carlos007, createdTime=Mon Oct 03 11:49:04 CST 2016, time=2016-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139131, encodeId=69251391318d, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sun Oct 02 17:54:22 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139130, encodeId=1835139130b8, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sun Oct 02 17:54:17 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139047, encodeId=60fc13904e36, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:05:23 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139046, encodeId=7cd11390466c, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:05:18 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139045, encodeId=39e51390456e, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:05:09 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139044, encodeId=e476139044dc, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:05:01 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139043, encodeId=2402139043d7, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:04:53 CST 2016, time=2016-10-02, status=1, ipAttribution=)]
    2016-10-02 doctorJiangchao

    继续关注

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=158795, encodeId=5982158e95cd, content=基因测序发现男性乳腺癌的易感基因——PALB2, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160903/IMG57CA05C7ADAC62159.jpg, createdBy=ea6c1943408, createdName=镱鉎鉌釚, createdTime=Tue Nov 29 07:04:08 CST 2016, time=2016-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=143102, encodeId=6bde143102c6, content=文章很好,继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Mon Oct 10 10:59:35 CST 2016, time=2016-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139490, encodeId=9d2f13949028, content=PALB2与男性及女性乳腺癌风险有关,提示应更多得对家族中有较多MBC及FBC病例但BRCA1 / 2突变阴性人群以临床研究。, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160923/IMG57E54D670B3C08868.jpg, createdBy=e90b1956497, createdName=Carlos007, createdTime=Mon Oct 03 11:49:04 CST 2016, time=2016-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139131, encodeId=69251391318d, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sun Oct 02 17:54:22 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139130, encodeId=1835139130b8, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sun Oct 02 17:54:17 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139047, encodeId=60fc13904e36, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:05:23 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139046, encodeId=7cd11390466c, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:05:18 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139045, encodeId=39e51390456e, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:05:09 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139044, encodeId=e476139044dc, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:05:01 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139043, encodeId=2402139043d7, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:04:53 CST 2016, time=2016-10-02, status=1, ipAttribution=)]
    2016-10-02 doctorJiangchao

    继续学习

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=158795, encodeId=5982158e95cd, content=基因测序发现男性乳腺癌的易感基因——PALB2, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160903/IMG57CA05C7ADAC62159.jpg, createdBy=ea6c1943408, createdName=镱鉎鉌釚, createdTime=Tue Nov 29 07:04:08 CST 2016, time=2016-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=143102, encodeId=6bde143102c6, content=文章很好,继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Mon Oct 10 10:59:35 CST 2016, time=2016-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139490, encodeId=9d2f13949028, content=PALB2与男性及女性乳腺癌风险有关,提示应更多得对家族中有较多MBC及FBC病例但BRCA1 / 2突变阴性人群以临床研究。, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160923/IMG57E54D670B3C08868.jpg, createdBy=e90b1956497, createdName=Carlos007, createdTime=Mon Oct 03 11:49:04 CST 2016, time=2016-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139131, encodeId=69251391318d, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sun Oct 02 17:54:22 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139130, encodeId=1835139130b8, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sun Oct 02 17:54:17 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139047, encodeId=60fc13904e36, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:05:23 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139046, encodeId=7cd11390466c, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:05:18 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139045, encodeId=39e51390456e, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:05:09 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139044, encodeId=e476139044dc, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:05:01 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139043, encodeId=2402139043d7, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:04:53 CST 2016, time=2016-10-02, status=1, ipAttribution=)]
    2016-10-02 9966699555

    谢谢分享,学习啦。

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=158795, encodeId=5982158e95cd, content=基因测序发现男性乳腺癌的易感基因——PALB2, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160903/IMG57CA05C7ADAC62159.jpg, createdBy=ea6c1943408, createdName=镱鉎鉌釚, createdTime=Tue Nov 29 07:04:08 CST 2016, time=2016-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=143102, encodeId=6bde143102c6, content=文章很好,继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Mon Oct 10 10:59:35 CST 2016, time=2016-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139490, encodeId=9d2f13949028, content=PALB2与男性及女性乳腺癌风险有关,提示应更多得对家族中有较多MBC及FBC病例但BRCA1 / 2突变阴性人群以临床研究。, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160923/IMG57E54D670B3C08868.jpg, createdBy=e90b1956497, createdName=Carlos007, createdTime=Mon Oct 03 11:49:04 CST 2016, time=2016-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139131, encodeId=69251391318d, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sun Oct 02 17:54:22 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139130, encodeId=1835139130b8, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sun Oct 02 17:54:17 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139047, encodeId=60fc13904e36, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:05:23 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139046, encodeId=7cd11390466c, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:05:18 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139045, encodeId=39e51390456e, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:05:09 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139044, encodeId=e476139044dc, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:05:01 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139043, encodeId=2402139043d7, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:04:53 CST 2016, time=2016-10-02, status=1, ipAttribution=)]
    2016-10-02 9966699555

    谢谢分享,学习啦。

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=158795, encodeId=5982158e95cd, content=基因测序发现男性乳腺癌的易感基因——PALB2, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160903/IMG57CA05C7ADAC62159.jpg, createdBy=ea6c1943408, createdName=镱鉎鉌釚, createdTime=Tue Nov 29 07:04:08 CST 2016, time=2016-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=143102, encodeId=6bde143102c6, content=文章很好,继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Mon Oct 10 10:59:35 CST 2016, time=2016-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139490, encodeId=9d2f13949028, content=PALB2与男性及女性乳腺癌风险有关,提示应更多得对家族中有较多MBC及FBC病例但BRCA1 / 2突变阴性人群以临床研究。, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160923/IMG57E54D670B3C08868.jpg, createdBy=e90b1956497, createdName=Carlos007, createdTime=Mon Oct 03 11:49:04 CST 2016, time=2016-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139131, encodeId=69251391318d, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sun Oct 02 17:54:22 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139130, encodeId=1835139130b8, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sun Oct 02 17:54:17 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139047, encodeId=60fc13904e36, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:05:23 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139046, encodeId=7cd11390466c, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:05:18 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139045, encodeId=39e51390456e, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:05:09 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139044, encodeId=e476139044dc, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:05:01 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139043, encodeId=2402139043d7, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:04:53 CST 2016, time=2016-10-02, status=1, ipAttribution=)]
    2016-10-02 9966699555

    谢谢分享,学习啦。

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=158795, encodeId=5982158e95cd, content=基因测序发现男性乳腺癌的易感基因——PALB2, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160903/IMG57CA05C7ADAC62159.jpg, createdBy=ea6c1943408, createdName=镱鉎鉌釚, createdTime=Tue Nov 29 07:04:08 CST 2016, time=2016-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=143102, encodeId=6bde143102c6, content=文章很好,继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Mon Oct 10 10:59:35 CST 2016, time=2016-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139490, encodeId=9d2f13949028, content=PALB2与男性及女性乳腺癌风险有关,提示应更多得对家族中有较多MBC及FBC病例但BRCA1 / 2突变阴性人群以临床研究。, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160923/IMG57E54D670B3C08868.jpg, createdBy=e90b1956497, createdName=Carlos007, createdTime=Mon Oct 03 11:49:04 CST 2016, time=2016-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139131, encodeId=69251391318d, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sun Oct 02 17:54:22 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139130, encodeId=1835139130b8, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sun Oct 02 17:54:17 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139047, encodeId=60fc13904e36, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:05:23 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139046, encodeId=7cd11390466c, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:05:18 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139045, encodeId=39e51390456e, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:05:09 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139044, encodeId=e476139044dc, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:05:01 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139043, encodeId=2402139043d7, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:04:53 CST 2016, time=2016-10-02, status=1, ipAttribution=)]
    2016-10-02 9966699555

    谢谢分享,学习啦。

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=158795, encodeId=5982158e95cd, content=基因测序发现男性乳腺癌的易感基因——PALB2, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160903/IMG57CA05C7ADAC62159.jpg, createdBy=ea6c1943408, createdName=镱鉎鉌釚, createdTime=Tue Nov 29 07:04:08 CST 2016, time=2016-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=143102, encodeId=6bde143102c6, content=文章很好,继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Mon Oct 10 10:59:35 CST 2016, time=2016-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139490, encodeId=9d2f13949028, content=PALB2与男性及女性乳腺癌风险有关,提示应更多得对家族中有较多MBC及FBC病例但BRCA1 / 2突变阴性人群以临床研究。, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160923/IMG57E54D670B3C08868.jpg, createdBy=e90b1956497, createdName=Carlos007, createdTime=Mon Oct 03 11:49:04 CST 2016, time=2016-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139131, encodeId=69251391318d, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sun Oct 02 17:54:22 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139130, encodeId=1835139130b8, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sun Oct 02 17:54:17 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139047, encodeId=60fc13904e36, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:05:23 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139046, encodeId=7cd11390466c, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:05:18 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139045, encodeId=39e51390456e, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:05:09 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139044, encodeId=e476139044dc, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:05:01 CST 2016, time=2016-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139043, encodeId=2402139043d7, content=谢谢分享,学习啦。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161002/IMG57F0B284885903774.jpg, createdBy=747b1625266, createdName=9966699555, createdTime=Sun Oct 02 15:04:53 CST 2016, time=2016-10-02, status=1, ipAttribution=)]
    2016-10-02 9966699555

    谢谢分享,学习啦。

    0

相关资讯

CSCO 2016:邵志敏教授——中国乳腺癌防治如何突破困境?

2016年,厦门的CSCO大会上,来自复旦大学附属肿瘤医院的邵志敏教授为我们讲述了中国乳腺癌的现状和问题。(邵志敏教授)乳腺癌是女性癌症第一位即使是从世界范围来说,乳腺癌也是位居女性癌症发病之首,全球每年新发乳腺癌病例约167.1万,每年约52.2万患者死于乳腺癌,发达国家乳腺癌发病率相对于欠发达国家更高。(乳腺癌世界地图,上图为发病率地图,下图为死亡率地图。可以看出,发达国家由于早筛等措施到

CSCO 2016:美国乳腺癌防治观念夺人眼球

2016年9月,台风刚过的厦门,CSCO大会如期召开。9月22日上午,美国癌症协会专家Angela DeMichele在CSCO-ASCO Joint Symposium上首先开讲——美国人是怎么搞乳腺癌防治的!讲者:DeMichele教授美国乳腺癌现状到2016年为止,美国乳腺癌患者数量为:246660例女性乳腺癌,为女性癌症的第一位;另有2600例男性乳腺癌。乳腺癌导致的死亡患者数量为40

Cancer:乳腺癌与血统有关,非裔发病率更高

Barbara Haley医生(左)和 Roshni Rao医生。(来源:德州大学西南医学中心)据美国《每日科学》报道,最新研究显示,线粒体基因测试可揭秘血统与特定类型乳腺癌发病率之间的关系。德州大学西南医学中心的癌症研究员通过分析一组三阴性乳腺癌患者的线粒体DNA后发现,有13%的患者并不了解他们的血统对癌症发病率有何影响。本研究第一作者,乳腺外科中心主任Roshni Rao医生说:“我们在92

Br J Cancer:饮食中的多氯联苯会不会增加乳腺癌、子宫内膜癌和卵巢癌风险?

多氯联苯(PCB)暴露对激素相关的癌症风险有什么影响?目前的观察性研究得出不一致的结论。本项研究旨在评估饮食中PCB暴露与乳腺癌、子宫内膜癌和卵巢癌风险的联系,研究对象为中、老年女性。 研究纳入了36777例基线(1997年)无癌症的女性,均来自以人群为基础的前瞻性队列研究SMC。通过食物频率问卷调查获得参与者饮食中PCB暴露情况。 在14年的随访中,乳腺癌、子宫内膜癌和卵巢癌分别发生

sci Rep:科学家开发出新型乳腺癌检测技术

近日,一项刊登于国际杂志Scientific Reports上的研究报告中,来自澳洲国立大学(Australian National University)的研究人员通过通过与法国的研究者合作开发出了一种有潜力的方法,该方法仅仅通过一种简单的血液检测方法就能够检测并且监测乳腺癌。 相比其它检测手段,比如乳腺癌活组织检查而言,血液检测手段比较便宜而且具有较低的侵入性,乳腺癌是一种常见的

JCEM:甲功里的这项指标与肺癌、乳腺癌风险有关

体外和体内实验均表明,甲状腺激素中存在抑癌和致癌的成分,但是基于人群的研究却得出不一致的结果。 本项以人群为基础的研究目的是,前瞻性评估甲状腺功能和癌症发生情况之间的关系。 该研究是一项基于人群的前瞻性队列研究,纳入了10318名参与者,基线测量游离甲状腺素(FT4)和/或促甲状腺激素(TSH)。 使用Cox比例风险模型来评估任何非皮肤癌的实体肿瘤风险;以及细分为肺癌、乳腺癌、前

Baidu
map
Baidu
map
Baidu
map